The level of the cardiac peptide NT-proBNP and indices of the scale of assessment of clinical status in chronic heart failure patients with ischemic cardiomyopathy

Abstract

This study focuses on the comparison of the level of NT-proBNP with indicators of the scale of assessment of clinical status in chronic heart failure patients with ischemic cardiomyopathy and identify possible correlations with the severity of symptoms included in this scale, features. There were 130 men with ischemic cardiomyopathy (mean age of 57,3±2,1 years). The results of correlation analysis in patients with ischemic cardiomyopathy revealed a positive correlation between the level of NT-proBNP with a total score on a scale of assessment of clinical status in chronic heart failure (r=0,756, p=0,0000), shortness of breath (r=0,602, p=0,0000), the weight change (r=0,541, p=0,0005), position in bed (r=0,428, p=0,008), degree of extensions neck veins (r=0,573, p=0,0002), wheezing in the lungs (r=0,428, p=0,008), enlargement of the liver (r=0,428, p=0.008), edema (r=0,641, p=0,0000). When the level of NT-proBNP with systolic blood pressure and disruptions in heart was not found.

Keywords

• ишемическая кардиомиопатия
• n-терминальный промозговой натрийуретический пептид
• шкала оценки клинического состояния при хронической сердечной недостаточности
• ischemic cardiomyopathy
• n-terminal pro-brain natriuretic peptide
• scale of assessment of clinical status in chronic heart failure